Septerna (SEPN) Asset Utilization Ratio (2024 - 2026)

Septerna's (SEPN) quarterly Asset Utilization Ratio came in at 0.12 in Q1 2026, up 5547.46% year-on-year from 0.0 in Q1 2025, and up 62.18% quarter-over-quarter from 0.08 in Q4 2025.

Septerna (SEPN) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Septerna's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.12 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 5547.46% year-over-year to 0.12 in Q1 2026; TTM through Mar 2026 was 0.12, a 5547.46% increase from a year earlier, with the FY2025 full-year figure at 0.09, up 2285.14% from the prior year.
  • Asset Utilization Ratio improved to 0.12 in Q1 2026 per SEPN's latest filing, from 0.08 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.12 in Q1 2026 and bottomed at 0.0 in Q2 2025.
  • The 3-year median for Asset Utilization Ratio is 0.02 (2024), against an average of 0.04.
  • Across the five-year window, Asset Utilization Ratio surged 2141.79% in 2025 and soared 5547.46% in 2026, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2024, then surged by 2141.79% to 0.08 in 2025, then soared by 62.18% to 0.12 in 2026.
  • Per Business Quant, the three latest SEPN Asset Utilization Ratio figures stand at 0.12 (Q1 2026), 0.08 (Q4 2025), and 0.04 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Septerna 1.50 Bn 1.50 Bn - 0.12

Historic Data

Download Data
DateValue
Mar 31, 2026 0.12
Dec 31, 2025 0.08
Sep 30, 2025 0.04
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00